Related Experiment Video
Updated: Jul 10, 2025

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Phys-DAT: A physiologically-based pharmacokinetic model for unraveling the dissolution, transit and absorption
Marina Cuquerella-Gilabert1, Javier Reig-López2, Jenifer Serna3
1Department of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Valencia, Spain; Interuniversity Research Institute for Molecular Recognition and Technological Development, Polytechnic University of Valencia-University of Valencia, Valencia, Spain; Simulation Department, Empresarios Agrupados Internacional S.A., Madrid, Spain.
This study developed a mechanistic model (Phys-DAT) for predicting oral drug absorption, demonstrating its accuracy and reliability comparable to existing physiologically-based pharmacokinetic (PBPK) software for BCS I and II drugs.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Computational Biology and Bioinformatics
- Pharmaceutical Sciences
Background:
- Physiologically-based pharmacokinetic (PBPK) software requires greater flexibility for complex LADME processes.
- In silico methods are crucial for efficient drug property testing and qualification.
- Oral drug absorption modeling demands advanced computational tools.
Purpose of the Study:
- To develop a mechanistic modeling framework (Phys-DAT) for dissolution, transit, and absorption processes.
- To integrate Phys-DAT into the PhysPK platform.
- To assess the predictive power of the acausal MOOM methodology within Phys-DAT against ODE-based PBPK software.
Main Methods:
- Developed a PBPK model incorporating thermodynamic states of the drug (unreleased, undissolved, dissolved).
- Represented the GI tract with nine compartments and first-order transit kinetics.
- Modeled dissolution using solubility-dependent/independent mechanisms and pH effects; employed linear transit and absorption mechanisms for passive diffusion.
- Validated the Phys-DAT model internally (simulation-based) and externally (in silico/in vivo data) for BCS I and II drugs.
Main Results:
- The Phys-DAT model accurately predicts plasma concentration profiles, Cmax, Tmax, and AUC0-t for BCS I and II drugs.
- Internal and external validations confirmed alignment with theoretical assumptions and good predictive performance.
- Calculations of AFE, AAFE, and PPE indicated that predicted/observed ratios were within acceptable ranges.
Conclusions:
- Phys-DAT provides a mechanistic approach to predict oral absorption, encompassing dissolution, pH effects, transit, and absorption.
- The PhysPK platform demonstrates strong prediction accuracy, comparable to ODE-based PBPK software.
- The Phys-DAT model shows reliable predictions for orally administered drugs in healthy volunteers, supporting the interchangeability of acausal MOOM methodology.
More Related Videos
10:33A Method for Determination and Simulation of Permeability and Diffusion in a 3D Tissue Model in a Membrane Insert System for Multi-well Plates
Published on: February 23, 2018
18:57Models and Methods to Evaluate Transport of Drug Delivery Systems Across Cellular Barriers
Published on: October 17, 2013
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Model Approaches for Pharmacokinetic Data: Physiological Models
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...